The impact of primary tumor location in patients with metastatic colorectal cancer: a Korean Cancer Study Group CO12-04 study
Jae Ho Byun, Joong Bae Ahn, Sun Young Kim, Jung Hun Kang, Dae Young Zang, Seok Yun Kang, Myoung Joo Kang, Byoung Yong Shim, Sun Kyung Baek, Bong-Seog Kim, Kyung Hee Lee, Soon Il Lee, Sang-Hee Cho, Byeong Seok Sohn, Samyong Kim, In Gyu Hwang, Eun Mi Nam, Bong-Gun Seo, Sang Cheul Oh, Myung-Ah Lee, Sang-Cheol Lee, Ji Hyung Hong, Young Suk Park
Korean J Intern Med. 2019;34(1):165-177.   Published online 2017 Nov 28     DOI:
Citations to this article as recorded by Crossref logo
Integrating Systemic Therapies into the Multimodality Treatment of Resectable Colorectal Liver Metastases
Omar Abdel-Rahman, Winson Y. Cheung
Gastroenterology Research and Practice.2018; 2018: 1.     CrossRef
Impact of primary tumor side on the outcomes of patients with non-metastatic colon cancer; a patient-level pooled analysis of two clinical trials
Anwar Giryes, Hani Oweira, Meinrad Mannhart, Omar Abdel-Rahman
Expert Review of Gastroenterology & Hepatology.2018; 12(8): 843.     CrossRef
Impact of Time to Start Systemic Therapy on the Outcomes of Patients with Metastatic Colorectal Cancer Treated with First Line FOLFOX Chemotherapy; a Patient-Level Pooled Analysis of Two Clinical Trials
Hani Oweira, Anwar Giryes, Meinrad Mannhart, Michael Decker, Omar Abdel-Rahman
Expert Review of Gastroenterology & Hepatology.2018; 12(10): 1069.     CrossRef
Prognostic Value of Baseline ALBI Score Among Patients With Colorectal Liver Metastases: A Pooled Analysis of Two Randomized Trials
Omar Abdel-Rahman
Clinical Colorectal Cancer.2018;[Epub]     CrossRef